Project Grant R01AI187028
Award Date
5/5/25
Completion Date
4/30/30
Dollars Obligated
$416K
Federal Agency
National Institute of Allergy and Infectious Diseases
Federal Grant Program
93.855
Assistance Type
Project Grant
Place of Performance
Georgia, USA
Similar Awards
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), aims to improve the understanding of how antibodies can control viral infections through Fc-dependent mechanisms such as antibody-dependent cellular cytotoxicity (ADCC), antibody-dependent cellular phagocytosis (ADCP), and complement-dependent cytolysis (CDC). The $318,085 award, effective from December 23, 2024 to...
This federal Project Grant award of $142,908.00 was provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The award supports research by the San Diego Biomedical Research Institute to examine how antibody glycosylation influences natural killer (NK) cell activity and antibody-dependent cellular cytotoxicity (ADCC) during HIV infection. The key research objectives are to determine how specific...
This $130,368 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), supports research aimed at defining how B cell receptor (BCR) binding site copy number at the cell surface is regulated to optimize antigen recognition and affinity-driven antibody selection. The primary objectives are to: 1) Determine the molecular mechanisms that underlie the developmental enhancement of BCR...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $470,989.00 in funding to North Carolina State University to systematically identify functional single nucleotide polymorphisms (SNPs) in the Fc gamma receptor (FcγR) locus and assess their impact on antibody-mediated immune functions, such as antibody-dependent cellular cytotoxicity (ADCC) and...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), supports research on the role of immunoglobulin genetic diversity in the development of neutralizing antibodies against the HIV envelope protein. The $242,310 award to Emory University, spanning from August 2024 to February 2027, aims to identify polymorphisms in rhesus macaques associated with differential development of...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $3,899,298 to Rockefeller University to conduct research on understanding the evolutionary processes governing antibody development within germinal centers. The key objectives are to develop a comprehensive toolset, including a mouse monoclonal model and deep mutational scanning experiments, to study the interplay...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) provides $837,497 to Yale University to conduct research focused on understanding the role of the PI3K-gamma enzyme in regulating antibody responses. The research aims to elucidate the molecular mechanisms by which PI3K-gamma orchestrates the differentiation of B cells into antibody-secreting plasma cells, with implications for...
This $586,250 Project Grant award was provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The funding supports research to investigate how distinct age-associated B cell subsets can protect the aged population from influenza. The primary focus is on understanding the potential of "age-associated B cells" (ABC) to respond to influenza infection and generate antibody-secreting cells, B...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $1,225,986 Cooperative Agreement under the Allergy and Infectious Diseases Research program (CFDA 93.855) to the University of Chicago. The grant, titled "Computational Models of Adaptive Immunity to Influenza," aims to investigate factors that determine strong, durable, and broadly protective adaptive immune responses to influenza vaccination, particularly in individuals with prior influenza virus exposure....
This $682,008 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) aims to advance the development of monoclonal antibody (mAb) therapeutics for the treatment of paramyxovirus infections, with a specific focus on parainfluenza virus (PIV). The key objectives are to: 1) define the human B cell repertoire to the PIV fusion (F) and hemagglutinin-neuraminidase (HN) surface proteins, 2)...